Form 4: HashiCorp CTO Armon Dadgar Reports Stock Sale

Sentiment:

SEC Filing


Armon Dadgar, CTO of HashiCorp, sold 35,904 shares of Class A Common Stock at a price of $33.7082 per share, according to a Form 4 filing.

Summary

  • Armon Dadgar, the Chief Technology Officer of HashiCorp, filed a Form 4 with the SEC.
  • The filing reports a transaction that occurred on August 2, 2024.
  • Dadgar sold 35,904 shares of Class A Common Stock at a price of $33.7082 per share.
  • The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on September 7, 2023.
  • Following the transaction, Dadgar directly owns 23,234 shares of Class A Common Stock.
  • Dadgar also indirectly owns 1,520,000 shares through the Armon Dadgar 2020 Charitable Trust, 282,617 shares through the Armon Memaran-Dadgar Living Trust, and 90,440 shares through Black Swan III, LLC.
  • Dadgar indirectly holds derivative securities convertible into 12,338,892 shares of Class A Common Stock through the Armon Dadgar 2020 Charitable Trust, 2,057,036 shares through the Armon Memaran-Dadgar Living Trust, and 601,328 shares through Black Swan III, LLC.
  • Dadgar directly holds derivative securities convertible into 480,916 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to an insider stock sale. It doesn't contain any information that would significantly sway sentiment positively or negatively. The sale was conducted under a pre-arranged plan, which mitigates potential negative interpretations.

Industry Context

This filing is a routine disclosure of insider trading activity. It's common for executives to sell shares under pre-arranged trading plans to avoid accusations of trading on inside information. The sale itself doesn't necessarily indicate a negative outlook for the company.

Stakeholder Impact

  • The stock sale by a key executive could be perceived negatively by some shareholders, although the existence of a pre-arranged trading plan mitigates this concern.

Key Dates

DateDescription
09/07/2023Date of adoption of Rule 10b5-1 trading plan
08/02/2024Date of stock sale transaction
08/05/2024Date of signature on the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.